|
HS Code |
247697 |
| Generic Name | Allopurinol |
| Brand Names | Zyloprim, Aloprim |
| Drug Class | Xanthine oxidase inhibitor |
| Indications | Gout, hyperuricemia, kidney stones, tumor lysis syndrome |
| Mechanism Of Action | Inhibits xanthine oxidase, reducing uric acid production |
| Route Of Administration | Oral, intravenous |
| Common Dosage Forms | Tablet, injection |
| Typical Adult Dose | 100-300 mg daily (varies by indication) |
| Common Side Effects | Rash, nausea, diarrhea, drowsiness |
| Contraindications | Hypersensitivity to allopurinol |
| Metabolism | Primarily hepatic, active metabolite oxypurinol |
| Pregnancy Category | C (US FDA) |
| Half Life | 1-2 hours (allopurinol), 15 hours (oxypurinol) |
| Excretion | Renal |
As an accredited Allopurinol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Allopurinol packaging: White cardboard box, labeled “Allopurinol Tablets 100 mg,” containing 28 film-coated tablets in a blister strip. |
| Shipping | Allopurinol is shipped as a solid, stable pharmaceutical compound in tightly sealed containers to prevent contamination and moisture exposure. Standard shipping regulations for non-hazardous chemicals are followed, maintaining temperature control if required. Proper documentation, including safety data sheets, accompanies each shipment to ensure safe handling and compliance with regulatory requirements during transit. |
| Storage | Allopurinol should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F), protected from moisture and light. It should be kept in a tightly closed container and out of reach of children and pets. Avoid freezing or exposing the medication to excessive heat. Always follow the manufacturer's guidelines for storage to maintain its effectiveness. |
|
Purity 99%: Allopurinol with purity 99% is used in pharmaceutical synthesis, where it ensures consistent inhibition of xanthine oxidase for reliable uric acid control. Molecular Weight 136.11 g/mol: Allopurinol at molecular weight 136.11 g/mol is used in oral tablet formulations, where it provides predictable pharmacokinetics and dosing accuracy. Melting Point 350°C: Allopurinol with a melting point of 350°C is used in high-temperature compounding processes, where it maintains structural integrity under thermal stress. Particle Size <10 µm: Allopurinol with particle size less than 10 µm is used in injectable formulations, where it facilitates rapid dissolution and homogeneous suspension. Stability Temperature 25°C: Allopurinol stable at 25°C is used in long-term storage conditions, where it preserves chemical efficacy and shelf life in pharmaceutical warehouses. Water Solubility 80 mg/L: Allopurinol with water solubility of 80 mg/L is used in oral liquid suspension preparations, where it enables accurate dosing and patient compliance. Residue on Ignition <0.1%: Allopurinol with residue on ignition less than 0.1% is used in quality-controlled drug manufacturing, where it minimizes contamination and enhances product purity. Identified by IR Spectrum: Allopurinol identified by IR spectrum is used in analytical quality control labs, where it ensures correct compound verification and reduces misidentification risk. Specific Rotation Neutral: Allopurinol with neutral specific rotation is used in enantiomeric purity testing, where it confirms the absence of optically active impurities. |
Competitive Allopurinol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Allopurinol steps into the spotlight for people who’ve battled the discomfort and helplessness of gout flare-ups. For those who wake up with a throbbing, red, and swollen toe, or find their joints stiff and on fire, this medication often brings real relief. Anyone who has felt that pain knows why an effective solution matters. Gout isn’t just about pain; it creeps into daily routines and can make a simple task turn into a grueling chore. Allopurinol offers a way to reclaim time lost to pain, making everyday movement possible again.
The main draw of Allopurinol comes from its targeted action. It helps the body cut down excess uric acid before it ever gets a chance to turn into painful crystals. Instead of just waiting for pain to strike, people can get ahead of it by using this medication every day. This is different from popping a pill to chase away a single attack. Living with gout means managing it all the time, and being proactive with prevention holds real promise for improvement.
Allopurinol is often identified by its chemical name, but the real heart of its function lies in how it manages uric acid production. Uric acid naturally wants to build up in blood, especially for folks with certain diets or genetic backgrounds. Where most common painkillers just take the edge off, Allopurinol goes straight for the source. It blocks the enzyme xanthine oxidase, a key step in turning purines into uric acid. By disrupting this chain reaction, the drug reduces the formation of uric acid at the source instead of waiting until trouble arises.
Many people don’t realize there’s a difference between treating pain and preventing it. Aspirin or ibuprofen might reduce swelling, but they won’t do much to keep uric acid levels low. Allopurinol isn’t aiming for fast relief — instead, it works in the background each day to keep things stable. This steady approach builds a strong foundation for long-term management, especially for people who see flares return over and over again.
Allopurinol comes in tablet form, typically at strengths of 100 mg or 300 mg. The lower dose, 100 mg, fits those just beginning their treatment or those with kidney sensitivity. The higher 300 mg version works for people with higher uric acid values or more persistent symptoms. Doctors often start patients low, letting the body adjust before bumping up the dose. This helps sidestep side effects and gives the body a chance to settle in with the medication.
Certain people need more careful monitoring — especially those with kidney issues. With chronic conditions, the kidneys handle waste removal, so a drug that changes what the kidneys process requires a trained eye. For people on a strict routine of other medications, the interaction with Allopurinol can also shape the dosage doctors recommend.
Some drugs try to flush uric acid from the body by making you urinate more. These medicines, known as uricosuric agents, are not always ideal for those with sensitive kidneys or histories of kidney stones. Allopurinol, in contrast, works upstream — it stops uric acid production before excess becomes a problem. This distinction sets it apart from options such as probenecid or febuxostat.
Febuxostat, another xanthine oxidase inhibitor, shares a similar mechanism but often comes under the microscope for its safety profile, especially for patients with heart disease. Many doctors look at allopurinol’s longer track record when making a decision. The clinical evidence around allopurinol stretches back for decades, building trust in its effects and the types of people who tend to respond well. That experience can make a world of difference for those choosing a treatment and hoping to avoid the risks tied to newer drugs.
Gout gets dismissed too often as just a sore foot, but those who feel real attacks know the toll it can take. People can find themselves keeping shoes tucked away and missing social events because they’re unsure when pain will strike. Beyond the physical suffering, there’s a ripple effect on sleep, work, and even relationships. It’s not just about chasing away flares; it’s about restoring some control to lives interrupted by pain.
Researchers point out that the prevalence of gout continues to rise. Cases have nearly doubled in the past 20 years. Diets high in processed meat, seafood, and alcohol, alongside sedentary lifestyles, make flare-ups more likely. Combined with the growing rates of diabetes, hypertension, and kidney disease, it’s clear more people could benefit from steady uric acid control.
Allopurinol stands as a reliable line of defense, especially for those already dealing with chronic illness. Doctors often point out its ability to lower serum urate levels well below the threshold needed to dissolve existing uric acid crystals. That’s not something over-the-counter remedies can promise.
For many, the hurdle is sticking with Allopurinol day after day, even if joints feel fine. Skipping doses can raise uric acid and pave the way for relapse. Those who stop and start often see the cycle repeat — relief followed by another punishing attack.
From real-world experience, some people worry about side effects, like skin rashes or gastrointestinal discomfort. Talking with doctors can build confidence and ensure any new symptoms get caught early. Most tolerate the medication without much trouble. For those who do have reactions, alternative dosing strategies or other medications can sometimes offer answers. Technology has even made it easier to track side effects and communicate with medical teams, so people have more agency in their treatment.
A change in mindset helps: Allopurinol works best for people who see it as a regular part of life, not a rescue medication. Using pill organizers or smartphone reminders keeps treatment on track. Community support, from online groups or local health programs, makes it easier to find motivation and information.
While most folks think about gout, high uric acid brings other risks. Research has connected elevated levels to kidney stones and certain patterns of kidney disease. In some rare conditions, such as tumor lysis syndrome, the body dumps a large amount of chemical waste into the bloodstream. Allopurinol steps in here, too, lowering the chance of kidney trouble.
Some studies even look into its role beyond uric acid — like protecting the heart or slowing certain aspects of diabetes. While these uses aren’t the main reason for prescriptions today, the ongoing research speaks to untapped potential. It’s clear that controlling uric acid touches more parts of health than just swollen toes.
The journey doesn’t always run smooth. Some patients stretch their prescriptions or hesitate at the pharmacy counter because of cost. While Allopurinol carries a reputation for being affordable — especially as it’s out of patent and widely available — even small expenses add up for those on fixed incomes or juggling a basket of other medications.
Other patients run into confusion or outdated advice. Old myths about “starting allopurinol triggers gout attacks” can create fear. Early in treatment, uric acid drops and may temporarily flush old crystals from tissues into the joints — causing pain. Doctors usually address this with medications like colchicine during the starting weeks, but not everyone hears this advice. Clear, repeated messaging matters.
Pharmacists step up as well, answering questions and catching problems with other medicines. They’re in a position to spot missed refills or catch dangerous combinations. Support from primary care teams makes all the difference. Seeing a familiar face who knows the routines and medical history builds trust and helps keep the journey steady.
While Allopurinol delivers clear benefits, the treatment journey faces bumps in the road. Misconceptions run deep, and not everyone has equal access to reliable information. For instance, language barriers, literacy, and health misinformation can result in people stopping treatment for the wrong reasons or not starting at all.
Monitoring uric acid sounds simple, but in practice, some folks rarely get follow-up blood tests. Busy schedules, transportation barriers, and gaps in health insurance hold many back from routine appointments. More outreach and community-based care options could close these gaps. People do better when the process feels less like a maze and more like a partnership between them and their care team.
My own work with patients has shown that communication matters more than anything. When people understand what to expect, side effects become scary only when ignored or hidden. Bringing family members into appointments helps support routines at home. Clinics that weave pharmacists, nurses, and nutritionists together make care more seamless.
Community health programs make a difference too — organizing informational sessions at churches, local clinics, or community centers creates space for questions and real discussion. Patients need more than a pamphlet: real stories, familiar faces, and open lines of communication bring the science to the ground level. It also helps debunk myths and replace panic with practical steps.
On the technology front, digital pillboxes and telemedicine platforms have knocked down some barriers. Reminders, chat-based check-ins, and automated refill requests put the logistics within reach for people who might struggle with memory or mobility. A little investment in these tools pays off in more stable uric acid levels and fewer flair-ups.
Insurance programs, community clinics, or even pharmaceutical assistance programs can bridge gaps around affordability. Programs that bundle multiple prescriptions raise adherence, saving costs down the road due to fewer emergency room visits or hospital stays.
Long-term control of chronic disease boils down to more than the medicine itself. Education sits at the crossroads. Without accurate, practical guidance, even the best medications collect dust on the shelf. People benefit from clear action steps: how to take Allopurinol every day, what foods to adjust in daily meals, and how to spot new symptoms early.
Community workshops, healthcare provider seminars, and online forums have all stepped up efforts to share clear, evidence-based advice. For example, teaching patients to keep a simple record of daily pills encourages consistency. Providing visuals on how uric acid changes over time helps make the numbers feel real — not just another lab report.
The more people feel empowered, the better their outcomes look. Patients who understand the “why” behind each part of the regimen have fewer drop-offs and more confidence talking with their care team when things feel off. Turning education from a one-time lecture into an ongoing dialogue builds better habits that last for years.
Medication alone can bring stability, but lifestyle changes amplify the results. People who adjust their intake of purine-rich foods often see faster progress. Cutting back on red meats, seafood, and sugary drinks lowers uric acid from another angle.
Alcohol, especially beer and spirits, also brings problems for uric acid management. Sometimes, even a small change can swing the numbers enough to reduce the risk of a sudden attack. People who keep moving, exercise regularly, and manage weight see less inflammation and better long-term outcomes.
Doctors and dietitians often team up here. They walk people through practical swaps — such as switching out beef for plant-based proteins or planning easy drink substitutes — instead of throwing out a long, one-size-fits-all list of foods to avoid. The best results spring from a partnership, not judgment.
The future of managing gout and high uric acid brings promise. Genetic tests can increasingly help identify which treatment fits best. Doctors use more data from wearable devices and patient-reported outcomes to track how things are going between visits. More people can get care outside the traditional clinic thanks to remote medicine.
Community health projects continue to close the gap for people who struggle to get care. Bringing nurses into home visits or pharmacy-based clinics puts knowledge and reassurance within easy reach. Social networks, both in-person and online, bolster long-term motivation and support.
Even with advancing science, the basics still matter most: people want relief from pain and freedom to move without constant worry. For many, Allopurinol lays the groundwork for that peace of mind. As resources grow and new research comes in, patients and doctors can adapt the approach to fit changing lives and new challenges.
Allopurinol has carved out its place as a mainstay for people managing gout and high uric acid. Its strength rests on dependable results, ease of use, and decades of research in real people facing real struggles. For those seeking more than just temporary relief, this medication offers the start of a better everyday experience. With good communication, steady support, and a willingness to learn, people regain control — one step, one meal, one pill at a time.